Background: Depression is one of the most frequently reported psychological problems following TBI, however prevalence estimates vary widely. Methodological and sampling differences may explain some of this variability, but it is not known to what extent. Methods: Data from 99 studies examining the prevalence of clinically diagnosed depression (MDD/ dysthymia) and self-reports of depression (clinically significant cases or depression scale scores) following adult, non-penetrating TBI were analysed, taking into consideration diagnostic criteria, measure, post-injury interval, and injury severity. Results: Overall, 27% of people were diagnosed with MDD/dysthymia following TBI and 38% reported clinically significant levels of depression when assessed with self-report scales. Estimates of MDD/dysthymia varied according to diagnostic criteria (ICD-10: 14%; DSM-IV: 25%; DSM-III: 47%) and injury severity (mild: 16%; severe: 30%). When self-report measures were used, the prevalence of clinically significant cases of depression differed between scales (HADS: 32%; CES-D: 48%) method of administration (phone: 26%; mail 46%), post-injury interval (range: 33-42%), and injury severity (mild: 64%; severe: 39%). Conclusion: Depression is very common after TBI and has the potential to impact on recovery and quality of life. However, the diagnostic criteria, measure, time post-injury and injury severity, all impact on prevalence rates and must therefore be considered for benchmarking purposes.
Prevalence of clinically significant levels of depression ('cases') following TBI . 
Introduction
Traumatic brain injuries (TBIs) can cause a variety of changes in cognitive, physical and psychological functioning, which may impact on all areas of a person's life. Cognitive changes include problems with memory and attention, poorer executive functioning and slowed information processing (Bay et al., 2012; Belmont et al., 2009; Konrad et al., 2011; Rochat et al., 2009) , with the physical consequences including headaches, sleep problems and fatigue (Cantor et al., 2012; Chaput et al., 2009; Mathias and Alvaro, 2012) . Psychological problems are also very common following TBI (for a review see Kim et al., 2007) , with the most widely recognised and researched of these being depression (Hart et al., 2012; Rapoport, 2012) .
The prevailing biopsychosocial model of health provides one framework for understanding some of the variables that may contribute to the development of these problems -including depression -following TBI (Helmchen, 2013) . Specifically, this model posits that illnesses are caused by a complex interaction between a range of biological, psychological and social factors, with a person's vulnerability to illness changing over time (Molina, 1983) . In the context of TBI, there are a variety of neuroanatomical changes that may provide a biological basis for the development of depression. For example, the shear, tensile and compressive strains experienced during a TBI can lead to diffuse axonal injury in the frontal and temporal lobes, disrupting the neural circuitry between the prefrontal cortex, amygdala, hippocampus, basal ganglia and thalamus (Jorge and Robinson, 2002; Kumar and Cook, 2002; Morris, 2010; Silver et al., 2009 ). This neuronal damage and cell loss can occur for weeks to months after an injury, and may provide the neurological substrate for many of the cognitive and psychological changes that occur after a TBI (Jorge and Starkstein, 2005; Sherin and Nemeroff, 2011) . Neurochemical changes, such as cholinergic and serotonergic deficits, neuroendocrinal abnormalities and compromised hypothalamic-pituitary-adrenal axis function, also occur in the acute period post-TBI; potentially also causing depression (Jorge and Starkstein, 2005; Rosenthal et al., 1998) . Psychological variables -such as a diminished tolerance to frustration, impaired self-awareness, low self-esteem, and poor coping strategies -may additionally lead to depression after a TBI (Kelley et al., 2012; Malec et al., 2007; Molina, 1983) . Lastly, a variety of social factors -including a lack of social support, the loss of personal relationships/friendships, unrealistic expectations and involvement in litigation -may independently contribute to the development of depression following TBI or exacerbate symptoms that arise from any of the aforementioned causes (Dikmen et al., 2003; Gunstad and Suhr, 2001; Iverson et al., 2010b; Waljas et al., 2014) . Thus, there are a large number of variables that may explain why depression is a common problem after TBI.
Estimates of the prevalence of depression following TBI vary considerably -ranging from 6% to 77% (Rutherford et al., 1977; Varney et al., 1987) . This variability not only seriously limits the clinical utility of these findings, but also raises questions about its source. Differences in how depression is conceptualised (diagnosed disorder vs self-reported symptoms), the diagnostic criteria and/or measures that are used to assess depression and a number of patient characteristics (e.g., injury severity), may explain a significant amount of this variance; however, we do not currently know to what extent these variables impact on estimates of the prevalence of depression following TBI.
The two most commonly diagnosed depressive disorders following TBI are major depressive disorder (MDD) and dysthymia (Gomez-Hernandez et al., 1997; Hibbard et al., 1998; Meares et al., 2011; Whelan-Goodinson et al., 2009a) , which are generally determined using one of two criteria, namely the Diagnostic and Statistical Manual of Mental Disorders (DSM-III, DSM-IV, DSM-5; American Psychiatric Association [APA], 1987 [APA], , 2001 [APA], , 2013 or the International Classification of Diseases (ICD-9, ICD-10; World Health Organisation, 1977 . These disorders have overlapping symptoms, including depressed mood, disturbed sleep, low energy and poor concentration. Whereas a diagnosis of MDD requires the presence of five or more symptoms during a 2-week period, dysthymia (also known as persistent depressive disorder) requires the presence of two symptoms for a minimum of 2 years (APA, 2013) .
MDD and dysthymia are frequently diagnosed using one of a number of structured clinical interviews to determine whether their patients meet DSM or ICD criteria (e.g., Structured Clinical Interview for DSM-IV Axis I Disorders [SCID-I]; First et al., 1997) . However, these interviews examine symptoms over different time periods -ranging from the previous week (e.g., the Clinical Interview Schedule [CIS]; Lewis et al., 1992) Robins et al., 1988) ; which may have a significant impact on the resulting prevalence rates. Not only can the symptoms vary between these time frames, but also memory and other cognitive problems following TBI may affect the accuracy of the information that is reported (Hilsabeck et al., 1998) . Therefore, differences in the diagnostic criteria and/or interview schedules that are used may be impacting on estimates of the prevalence of MDD and dysthymia.
Prevalence rates may additionally be affected by a number of sample characteristics, including the time interval between the injury and when depression is assessed. Some studies have found that MDD is more prevalent in the early stages after an injury (Bombardier et al., 2010; Lin et al., 2010) , possibly reflecting neuroanatomical abnormalities or the cascade of neurochemical changes that occur in the acute post-TBI period (Jorge et al., 1993a) . Conversely, others have found MDD and/or dysthymia are more common in the long-term (Al-Adawi et al., 2007; Rao et al., 2010) , which may be more indicative of the psychosocial challenges faced by individuals as they adjust to their altered life circumstances (e.g., lack of social support, reduced social functioning) (Jorge et al., 1993b) . Similarly, the severity of an injury can range from minor to severe, with some studies examining mixed samples (mild, moderate and severe), others targeting specific injuries (e.g., mild or severe), and still others examining less common categories, such as minor (Van Der Horn et al., 2013) or complicated mild TBI (Bombardier et al., 2010; Fann et al., 2005; Juengst et al., 2013) .
In addition, control groups are often also recruited to examine the base-rates of depression because depression is not unique to TBI, but the samples chosen for this purpose can vary. Typically, medical patients (Brown et al., 2004; Jorge et al., 2004) , people from the general community (Belmont et al., 2009; Konrad et al., 2011; Ponsford and Ziino, 2003) , or family and friends of the TBI group (Perlesz et al., 2000; are used for this purpose. Each one attempts to control for the potential impact of different variables (e.g., illness-related stress) on the prevalence of depression and, therefore, the base-rates are likely to differ between these groups. Once again, it is not known whether or how the choice of control groups impacts on the conclusions that are drawn regarding post-TBI rates of depression when they are used for comparative purposes.
Also important is the distinction between clinical diagnoses of MDD/dysthymia and assessments that use self-report questionnaires (e.g., Beck Depression Inventory [BDI]; Beck et al., 1996) to assess depression on a continuous scale (minimal to severe); often with the additional ability to identify clinically-significant levels of depression ('cases') using designated cut-off scores (dichotomous scale). Self-report scales are frequently used in clinical settings to screen for depression and in research settings to examine the prevalence and severity of depression following TBI. However, many of these scales were not specifically designed for use with TBI groups or in medical settings; instead being intended for use with the general population (e.g., Center for Epidemiological Scale -Depression [CES-D]; Radloff, 1977) or psychiatric patients (e.g., Hamilton Depression Rating Scale [HAM-D]; Hamilton, 1960) . Consequently, they may contain items that can be affected by the physical consequences of a TBI (e.g., poor sleep, fatigue), which may inflate the prevalence of depression.
Furthermore, the way that clinicians or researchers administer questionnaires may affect the depression scores obtained on selfreport scales. Various administration methods have been used, with some participants completing them at the research site (Hudak et al., 2011; Konrad et al., 2011) , in their own home (Bushnik et al., 2008; King and Kirwilliam, 2011) , over the phone (Bombardier et al., 2010; Hart et al., 2011) or by using a combination of these methods (Hawthorne et al., 2009; Smith, 1992) . Specifically, certain situations may elicit socially-desirable responses, provide fewer opportunities to reflect on and revise answers (e.g., telephone interviews), or be subject to other unidentified influences (e.g., mailed: when completed and whether completed alone/with others). These variables are known to have an impact on people's responses (for a review see Richman et al., 1999) and, consequently, should be considered in the current context.
Any one or more of these variables has the capacity to influence estimates of the prevalence of depression and may help to explain why the aforementioned statistics vary so widely. However, as yet, their impact has not been assessed. A systematic analysis of the prevalence of depression following TBI is needed to evaluate the impact of these variables and to assist clinicians in selecting the most appropriate benchmark(s) for their particular circumstance. The current study therefore meta-analysed existing research that has examined: (1) the prevalence of clinical diagnoses of MDD and dysthymia following TBI or (2) used self-report scales to assess the prevalence of clinically significant symptoms and/or the severity of depression. To this end, the impact of diagnostic criteria, interview schedule, post-injury interval and injury severity on the prevalence of MDD/dysthymia was evaluated, as was the type of control group. In addition, the impact of questionnaire, method of administration, post-injury interval, injury severity and type of control group on self-reported measures of depression was examined.
Methods

Literature search, inclusion and exclusion criteria
Comprehensive searches of the PsycINFO, Pubmed, Scopus, and ISI Web of Knowledge electronic databases, from January 1980 to June 2013, were undertaken to identify studies that examined depression following TBI using search terms that were tailored for each database (see Supplementary data: Table A ). In addition, the reference lists of all studies that were included in the final analysis were examined to identify any other relevant research.
For a study to be included in the current meta-analysis, it had to meet the following criteria: (1) it examined depression following non-penetrating TBI; (2) participants were 18 years or older (where age range was not provided: mean age minus 1 SD ≥18); (3) it reported the prevalence of current MDD or dysthymia, which was formally diagnosed using DSM or ICD criteria, and/or 'cases' (clinically significant levels of depression), or depression scale scores from a common self-report depression scale (excludes general quality of life and mood-state measures, and study-specific or modified scales) (see Supplementary data: Table B for a list of eligible measures); (4) data were provided for a TBI sample (single-sample) or both a TBI and control group (independent samples); (5) the data (prevalence rates, cases or depression scores) were reported in a way that enabled the calculation of an effect size; (6) the data were published in a journal in English and contained original data (excludes reviews); and (7) the sample size was greater than 15 (excludes very small samples and case studies).
Studies were excluded if participants were drawn exclusively from very specific or at-risk TBI populations -such as war veterans, prison inmates, victims of large-scale trauma/terrorism, or psychiatric populations -as their exposure to other traumatic events/situations may have increased their vulnerability to depression, rendering them less comparable to the broader TBI population. In addition, control groups were excluded if the group was very specific (e.g., depressed controls), depression was not assessed, or different depression scales were administered to the TBI and control groups. Moreover, if a study examined the efficacy of some form of treatment, only the pre-treatment data were analysed.
The literature search initially identified 8,399 potentially relevant articles, 2,217 of which were duplicates. The titles and abstracts of the remaining 6,182 articles were screened by the first author (AJO) using the aforementioned inclusion and exclusion criteria, after which the full-text versions of 459 studies were retrieved for detailed screening. Re-application of the inclusion criteria to these papers reduced the number of eligible studies to 99 (see Supplementary data: Table C for an overview of the study review and selection process). In ambiguous cases, papers were independently assessed by AJO and JLM, and eligibility determined following discussion.
Data that are meta-analysed must be obtained from independent samples (Rosenthal, 1995) ; consequently all studies were checked to establish independence. Six samples were followed longitudinally (two articles each); the data from these articles were combined, resulting in six independent studies; further reducing the final number of eligible studies to 93. Moreover, the data for the control groups from five studies were unsuitable for present purposes: only the TBI data from these studies were extracted (Capizzano et al., 2010; Hawthorne et al., 2009; Reza et al., 2007; Schnabel and Kydd, 2012; Wood and Williams, 2008) .
Data preparation
Some basic data preparation was needed in order to render it suitable for analysis. Specifically, where demographic details were reported for TBI subgroups that were not relevant to the current analyses (e.g., fatigued vs non-fatigued TBI patients), the data were combined. If median and range were reported (e.g., age), the mean and SD were estimated using the methods recommended by Hozo et al. (2005) . In addition, where necessary, standard errors were transformed to standard deviations and descriptive data transformed to a common scale of measurement (e.g., time-since-injury: months).
The post-injury interval for studies varied widely -ranging from a few days to over 30 years -necessitating the classification of these intervals into four broad groups: the first included studies that examined mean post-injury intervals of <6 months (acute to post-acute period); the second included intervals of ≥6 months to <2 years (short term); the third spanned ≥2 years to <5 years (medium term); and the fourth ≥5 years (long-term). Unfortunately, very few studies reported separate prevalence rates for their mild, moderate and severe participants. Thus, the data from studies that examined mild-moderate and moderate-severe TBI samples were combined with those that assessed all three categories (mild, moderate and severe) for present purposes. Further, where studies assessed depression in a control group, the type of control was classified into one of three groups: 'medical controls' (spinal cord, orthopaedic or general trauma patients), 'general community', or 'significant other' (family/friends/ caregivers).
Data collection and effect size calculation
Demographic and injury information (e.g., age, gender, timesince-injury, injury severity data), the method by which depression was assessed (e.g., clinical diagnosis of MDD/dysthymia or selfreport measure), the criteria used to diagnose MDD/dysthymia (e.g., DSM-IV, ICD-10), the measure used (clinical diagnoses: SCID-I, SCAN, etc., self-report: BDI, Hospital Anxiety and Depression Scale [HADS], etc.), the method by which self-report scales were administered (research centre, phone, mail, or combination of methods), sample details (i.e., recruitment source, pre-injury history of mental health problems and TBIs, current medication use, type of control group [medical, community, significant other]), and statistical data necessary for the calculation of effect sizes were extracted from each study for analysis. This information was then entered into Comprehensive Meta-Analysis Software version 2 (CMA; ©2006, Biostat, Inc., Englewood, NJ, USA).
Three types of effect size were calculated in the current study. Firstly, proportions were used to summarise the prevalence of (1) clinically diagnosed cases of MDD and dysthymia, and (2) clinically significant levels of depression, based on self-report data ('cases'), in studies that used single (TBI) or independent (TBI and controls) samples designs. Weighted mean prevalence rates were calculated using sample size as the weighting variable. Secondly, odds ratios were calculated to measure any increase (OR >1) or decrease (OR <1) in the likelihood of experiencing depression following TBI for those studies that used self-report measures to identify clinically significant levels of depression (cases) in TBI and control groups. Thirdly, weighted standardised mean differences (Hedges g) were used to estimate the magnitude of the difference between the depression scale scores (means, SDs) of TBI and Control groups (independent samples study design). A positive Hedges g indicates that the TBI group reported higher levels of depression than the controls, with a small effect defined as ≥.2, a moderate effect as ≥.5, and a large effect as ≥.8 (Cohen, 1992) . As a guide, a Hedges g of .5 (medium effect) indicates that the means of the two groups differ by half of a pooled standard deviation.
The current study used a conservative random-effects model to calculate effect sizes, which assumes that effect sizes can vary due to sampling error and differences in study design. Importantly, when a study reported multiple scores that were eligible to be included in the same analysis, a mean effect was calculated to ensure that each study only contributed one effect size to any given analysis (Lipsey and Wilson, 2001) . Forest plots were generated to examine the effect size distributions and assist in identifying outliers (Boyles et al., 2011) , and ninety-five percent confidence intervals (95% CIs) were calculated to provide the upper and lower bounds within which we can be 95% confident that the actual population prevalence rate for depression following TBI lies. In the case of Hedges g, 95% CIs do that do not include zero, indicate that there is a significant difference between the depression scores of the TBI and control groups.
One problem that meta-analyses face is that the research literature may be biased towards publishing studies that report significant findings (publication bias/file-drawer problem) and, consequently, the resultant analyses tend to exclude nonsignificant findings; thereby inflating the effect sizes (Rosenthal, 1979) . Publication bias was assessed using Orwin's (1983) Failsafe N statistic (N fs ), which estimates the number of unpublished studies that would be required to draw a finding into question. Orwin's formula requires three values to compute a N fs : the number of studies contributing to a mean effect, the resulting weighted mean effect size, and an alternative mean effect size, below which a result would be considered inconsequential/of minor clinical significance. For current purposes, TBI prevalence rates of less than 7.5%, odds ratios of <1.0, and Hedges g values of <0.15 were deemed to be of minor clinical significance. These figures were chosen on the basis of (a) a population-based survey of the 12-month prevalence of depression in Australian adults (Australian Bureau of Statistics, 2008), (b) Hopkin's (2002) guidelines for a trivial effect when using odds ratios, and (c) Cohen's definition of a small standardised mean difference. The resulting N fs indicates the number of unpublished studies, with non-significant findings, that would be required to render the current findings inconsequential. Therefore, the larger the N fs , the more confidence we can have in a finding.
Statistical analyses
Consistent with recommendations made by the Meta-Analysis of Observational Studies in Epidemiology (MOOSE) group Stroup et al. (2000) , the impact of a variety of methodological and sampling variables on findings were examined in order to address the fact that findings from different studies were heterogeneous. This approach is also suggested by Borenstein et al. (2009) who note that a random-effects model and subgroup analyses can be used to identify sources of variability in the data.
The overall prevalence of MDD and dysthymia was calculated on the basis of data extracted from studies that used a singlesample (TBI group) or independent samples (TBI + controls) design, after which the impact of a number of moderator variables on the prevalence of MDD and dysthymia was examined, namely the: diagnostic criteria (DSM-III, DSM-IV, ICD-10); clinical interview (SCID-I, SCAN, etc.); time post-injury (<6 months, ≥6 months to <2 years, ≥2 years to <5 years, ≥5 years); and injury severity (i.e., mild, mild-moderate-severe, severe). In addition, the prevalence of MDD and dysthymia, relative to controls, was examined using ORs; both overall and based on the type of control group (medical, community, significant other).
Next, studies that used self-report scales to identify clinically significant levels of depression were examined. The overall prevalence of depression (cases) was calculated using data from single and independent samples designs, and the following moderator variables examined: the self-report scale (BDI, HADS, etc.); the method of administration (research centre, phone, mail, or combination of methods); time post-injury; and injury severity. The prevalence of clinically significant levels of depression (cases), relative to controls, was examined using ORs -both overall and by type of control group. Finally, the depression scale scores of TBI and control groups (level/severity of depression) were compared using Hedges g -both overall and by type of control group. Note: N studies and N participants refer to the total number of studies and participants for which data were available. One study used two different control groups: community and medical (Clarke et al., 2012) .
Results
Participant details
The 93 studies included in this meta-analysis provided data for a total of 11,926 participants. The background demographic and injury data for these studies are summarised in Table 1 , where it can be seen that the majority of participants were young to middleaged males.
Most studies reported the mean time between injury and assessment (N studies = 92), with the average interval being just under 3 years (see Table 1 ). In contrast, only a limited number of studies reported mean Glasgow Coma Scale scores (GCS) (N studies = 32), although most provided categorical information relating to injury severity. The majority of studies examined mixed samples of mild, moderate and severe TBI (N studies = 46), however most did not report separate outcomes for these sub-groups.
Participants were largely recruited from outpatient settings (N studies = 84; see Table 1 ). Six studies recruited from inpatient settings, all of which examined depression 1-6 months after severe TBI. Thirty-eight studies included participants who had a pre-injury diagnosis of depression or anxiety (779 out of 5,784 participants), 15 excluded participants on this basis, and 40 did not specify. Although the majority of studies failed to report whether participants had previously sustained a TBI (N studies = 60) or excluded participants with such a history (N studies = 21), 12 studies reported that 167 of their 1,146 participants had previously sustained a TBI. Similarly, most studies (N studies = 75) failed to report medication use, however 11 reported that 314 (out of 1,180) participants were taking medications for depression or anxiety. Finally, 30 studies recruited one or more control groups (see Table 1 ), with the majority using medical (N studies = 11; primarily general trauma) or community (N studies = 13) controls, and a further seven recruiting significant others (family, friends, caregivers of the TBI group).
Prevalence of formally diagnosed depression following TBI
The data from all studies that reported the prevalence of MDD and/or dysthymia following TBI (N studies = 31, N participants = 5,678) were combined in order to calculate an overall prevalence rate. Fig. 1a provides a forest plot of the prevalence rates for each of the individual studies (rank-ordered by size), together with the overall weighted mean, which indicates that, on average, 27% were diagnosed with MDD or dysthymia after a TBI. The associated N fs was very large (N fs = 81), suggesting that publication bias is unlikely to be a problem. Importantly, there was substantial variation in the prevalence estimates of individual studies (range: 9-67%), highlighting the need to undertake additional analyses to examine some of the variables that may have contributed to this variability.
Studies were first partitioned according to the diagnostic criteria that were used and, as seen in Fig. 1b , most used DSM criteria. Table D for details of studies contributing to the summary analyses in this figure; Kreutzer et al., 2001 used the NFI to identify and quantify depressive symptoms of MDD as specified in the DSM-IV. The lowest prevalence rate (14%) was obtained using ICD-10 criteria and the highest (47%) using DSM-III criteria. Moreover, the CIs for ICD-10, DSM-IV and DSM-III prevalence rates did not overlap, indicating that they yielded significantly different rates.
As seen in Fig. 1c , a total of 10 different interview schedules were used to diagnose MDD/dysthymia, with the SCID-I (N studies = 13) being the most commonly used, followed by the SCAN, Mini International Neuropsychiatric Interview (MINI; Sheehan et al., 1998) , Present State Examination (PSE; Wing et al., 1974) and Patient Health Questionnaire (PHQ-9; Kroenke et al., 2001) , which were each used by three studies. The prevalence rates obtained using these measures varied between 16% and 33%; although, with the exception of the MINI and PSE, these differences were not significant. In contrast, the interviews used by single studies (e.g., CIDI, CIS, clinical diagnosis based on the Neurobehavioral Functioning Inventory [NFI]; Kreutzer et al., 1999) yielded significantly higher prevalence rates (range: 42-54%) than the more commonly used measures (i.e., SCID-I, SCAN and MINI).
Next, post-injury interval was examined to determine whether this impacted on prevalence rates (see Fig. 1d ). The mean time intervals for the acute/post-acute, short, medium and long-term studies were 2.4 months (SD = 1.4), 11.5 months (SD = 5), 3.1 years (SD = 0.8) and 10.5 years (SD = 6.5), respectively. Notably, the mean prevalence of MDD/dysthymia appears to increase in the first 5 years after a TBI (21-43%), after which it declines to acute/post-acute levels (22%). Moreover, the mediumterm prevalence rate was significantly higher than any other period.
Although injury severity may impact on the prevalence of depression after a TBI, only a coarse-grained analysis of this variable was possible because many studies used mixed samples (e.g., mild, moderate and severe) and only provided data for the whole sample. As seen in Fig. 1e , mild TBI was associated with a significantly lower prevalence of MDD and dysthymia (16%), compared with the mixed sample category of mild, moderate and severe TBI (30%). Severe TBI was only examined by one small-scale study with a wide CI that overlapped with the other categories, indicating that it did not differ from them in terms of the prevalence of MDD/dysthymia. Finally, data from five studies that compared the prevalence of MDD/dysthymia in TBI and control groups were examined (N participants : TBI = 600; controls = 712) (see Fig. 1f ). Overall, there was a higher prevalence of MDD/dysthymia following TBI (23%) than in the controls (17%), with the associated OR indicating that a person is 1.66 times more likely than controls to develop MDD or dysthymia after a TBI. There was considerable variation in the ORs for individual studies (.67-7.69), some of which may have resulted from the choice of control groups. Of the five studies, four used medical controls and only one used community controls. Importantly, after sustaining a TBI, a person is nearly eight times more likely to develop MDD or dysthymia (OR = 7.69) than someone from the general community but only one and a half times more likely than medical controls (OR = 1.55) (see Fig. 1g ).
Prevalence of clinically significant levels of depression ('cases') following TBI
When the data from the 57 studies that used self-report scales to identify clinically significant cases of depression following TBI were combined, it was found that the overall prevalence was 38% (refer to Fig. 2a ) . The associated N fs statistic was very large (N fs = 232), indicating that this is a very robust finding. As with diagnoses of MDD and dysthymia, there was considerable variability in the number of cases reported by individual studies (range: 2-74%), again highlighting the importance of examining some of the variables that may impact on these findings.
In terms of methodology, the specific self-report scale may impact on the prevalence of clinically significant cases of depression (see Fig. 2b ). Indeed, there was considerable variability in the mean prevalence rates that were obtained using these different scales, ranging from 2% for the Montgomery-Asberg Depression Rating Scale [MADRS] (Montgomery and Asberg, 1979) to 48% for the CES-D. However, as is evident from the CIs, the prevalence rates reported by studies using the same measure were also highly variable (e.g., BDI-II; Zung Self-rating Depression Scale [ZSDS]; Zung, 1965) , so much so that after excluding the MADRS, which was only used by one small study, none of the other measures differed significantly; although the HADS and CES-D approached significance. Similarly, when studies were grouped on the basis of how they administered the self-report scale -by phone, in person (research centre), by mail or using a combination of methods -there was substantial variability in the number of cases of depression reported by studies using the same method. Interestingly, although only the 'combination' and 'mailed' groups differed significantly, there was a trend towards fewer cases when questionnaires were administered by phone, compared to mailed questionnaires (see Fig. 2c) .
Next, the prevalence of clinically significant cases of depression was found to steadily increase, albeit not significantly, as the postinjury interval increased (see Fig. 2d ), with estimates ranging from 33% in the acute/post-acute period, 35% in the short-term, 41% in the medium term, and 42% in the longer term. Moreover, mild TBIs were associated with significantly more cases of depression (64%) than the mixed (mild/moderate/severe: 36%) and severe (39%) (see Fig. 2e ) TBI samples.
Finally, the data from the 16 studies that used self-report measures to identify cases of depression in TBI and control samples were examined (N participants : TBI = 1,055; controls = 1,000) (see Fig. 2f ). The overall mean prevalence of depression following TBI (44%) was substantially higher than that of control groups (19%), with the associated OR of 3.41 indicating that a person is nearly three and a half times more likely to report clinically significant depression after a TBI, compared to controls. Once again, the ORs for individual studies varied substantially (range: 1-49), raising the possibility that the type of control group impacted on these findings. As seen in Fig. 2g , controls from the general community reported the lowest rates of depression (9%), followed by significant others (23%) and medical controls (36%). This was reflected in the ORs, which indicated that, following a TBI, people are nearly six times more likely than those in the general community, three times more likely than their significant others (family, friends), and over twice as likely as those with other medical conditions to experience clinically significant levels of depression. Nevertheless, all CIs overlapped, indicating the aforementioned differences were not significant.
Self-reported levels of depression: TBI vs controls
Twenty studies provided mean depression scale scores (continuous data) for TBI and Control groups, which were examined (N participants : TBI = 1,563; controls = 4,017) using Hedges g (weighted standardised mean difference). Overall, there was a moderate and significant difference in the depression scores of the TBI and control groups (Hedges g = 0.63), together with a large N fs statistic (N fs = 43) (see Fig. 3a ). When these studies were grouped according to type of control group (medical/community/significant other), there was a large and significant difference between the depression scores of the TBI and community controls (see Fig. 3b ). Medical and 'significant other' controls also had significantly lower scores than the TBI group, but these differences equated to small to low-moderate effects.
Discussion
Estimates of the prevalence of depression following TBI vary widely, limiting the clinical utility of this research. The present study analysed the data from research that has examined the prevalence of MDD/dysthymia or used self-report scales to assess the severity of depression following TBI. A variety of methodological (diagnostic criteria, interview schedule/self-report scale, method of administering self-report scales, control group) and patient (time post-injury, injury severity) variables were examined to determine whether, and to what extent, they impacted on the available findings.
Overall, the findings indicate that depression is extremely common after a TBI, with 27% of people receiving a formal diagnosis of MDD or dysthymia and 38% reporting clinically significant symptoms on self-report scales. The lower prevalence of clinical diagnoses is not surprising because, in addition to using more stringent criteria, they provide a detailed assessment of the aetiology and chronology of symptoms, and greater opportunities for clarification (APA, 2000) . In contrast, self-report scales measure the presence and severity of symptoms, applying a threshold to identify clinically significant cases; and do not provide an opportunity to clarify whether symptoms are the result of preexisting (e.g., prior psychiatric history) or co-morbid conditions (e.g., physical/cognitive consequences of a TBI), which may inflate the prevalence rates (Green et al., 2001; Schwarzbold et al., 2008) .
Moreover, people report more symptoms when prompted with specific questions than when asked to freely recall them Fig. 2 . Prevalence of clinically significant levels of depression identified using self-report scales: (a) overall, (b) self-report scale, (c) method of administration, (d) time post-injury, (e) injury severity, (f) overall, relative to controls, and (g) according to the type of control group. Note: CI, confidence interval; N fs , fail-safe N; MADRS, Montgomery-Asberg Depression Rating Scale; HADS, Hospital Anxiety and Depression Scale; GDS, Geriatric Depression Scale; ZSDS, Zung Self-rating Depression Scale; BDI, Beck Depression Inventory; Leeds, The Leeds Scale for the Self-assessment of Anxiety and Depression; CES-D, Center for Epidemiological Scale -Depression. Refer online Supplementary data: Table D for details of studies contributing to the summary analyses in this figure. (Iverson et al., 2010a) , also leading to higher prevalence rates. The cognitive changes associated with TBIs (e.g., poorer memory, impaired insight) can, however, lead to fewer reports of depression (Wallace and Bogner, 2000) ; the impact of which may be offset by using questionnaires. Regardless of the method of assessment, individuals may exaggerate their symptoms if they are seeking financial compensation, highlighting the importance of assessing symptom validity when disingenuous performance may be an issue (Whiteside et al., 2012) . Once compensation claims have been settled, the motivation to exaggerate symptoms is likely to reduce, suggesting that longer-term prevalence rates are less likely to be affected by this. Estimates of the prevalence of MDD and/or dysthymia differed when different diagnostic criteria were used, with the highest rates noted for the DSM-III (47%) and DSM-IV (25%) criteria, decreasing to 14% for the two studies that used ICD-10 criteria. These differences are surprising, given the overlap between these criteria and the fact that the DSM-IV revisions were relatively conservative (First, 2010) . However, unlike the DSM, the ICD-10 categorises symptoms into two groups, each of which has a diagnostic threshold; potentially resulting in cases that meet one criterion, but not the other and leading to fewer diagnoses (First, 2009) .
Prevalence rates were also affected by the specific interview that was used to diagnose MDD and dysthymia. The most commonly used schedule -the SCID-I -yielded a prevalence rate of 23% (N studies = 13), with the others ranging from 16% (MINI: N studies = 3) to 54% (CIS; N studies = 1). Some of this variability may result from the different time frames that are assessed. Indeed, the CIS and Schedule for Affective Disorders and Schizophrenia (SADS; Endicott and Spitzer, 1978) , which focus on the preceding week, had the highest rates (54% and 50%, respectively). Longer time frames (previous 2 weeks to month) yielded substantially lower rates (e.g., MINI = 16%; SCAN = 18%; SCID-I = 23%). Other scales allow clinicians to select the time-frame (e.g., Diagnostic Interview Schedule; Robins et al., 1981) , but this was often not reported.
There was also considerable variability in the prevalence of clinically significant cases of depression, identified on the basis of self-report scales; with estimates ranging from 2% for the MADRS (N studies = 1) to 48% for the CES-D (N studies = 8). Notably, the CES-D was designed for use in the general population and incorporates items that may be indicative of physical or cognitive TBI symptoms (e.g., sleep difficulties, fatigue, attentional problems), possibly inflating the number of 'cases'. Interestingly, the rate obtained from the most frequently used scale -the HADS (N studies = 19; 32%) -was substantially lower than the finding for the CES-D (48%). The HADS was specifically designed for use in medical settings and, consequently, does not include items that may reflect the physical, rather than psychological, consequences of a TBI (Zigmond and Snaith, 1983) . This measure may therefore provide the best estimate of self-reported cases of depression.
The prevalence of self-reported 'cases' of depression also differed according to how the scale was administered. Specifically, more cases were identified when people completed questionnaires at home and returned them by mail (46%), than when completed by phone interview (26%). Phone administration may encourage people to respond in a socially-desirable manner, possibly causing them to down-play their symptoms and/or provide limited opportunity to reflect on and revise their answers (Aziz and Kenford, 2004; Fairweather-Schmidt and Anstey, 2012) . However, at home, a person may be influenced by others, even when there are explicit instructions stating that all responses must be their own and/or no discussion with others is permitted (Alfano et al., 1993; O'Carroll et al., 1991) .
In addition, prevalence rates varied according to the post-injury interval, with the prevalence of MDD/dysthymia steadily increasing in the first 5 years post-TBI (21-27-43%) and subsequently declining to a level similar to that seen in the early post-injury period (22%). In contrast, the number of 'cases' of depression identified using questionnaires steadily increased -although not significantly -from the acute/post-acute period until the medium-term (33-41%), when it plateaued. These findings highlight temporal changes to the risk of developing depression, possibly reflecting the changing influence of a number of different variables (e.g., neuronal/neurochemical, psychological, social). They also underscore the importance of monitoring individuals over an extended period of time and providing ongoing access to mental health support services.
Unfortunately, injury severity could only be examined in a basic way, due to the limited availability of data. These analyses revealed that mild TBI was associated with the lowest prevalence of MDD and dysthymia (16%); a rate that was significantly lower than that seen in mixed samples (30%). Although lower than the rate for severe TBI (30%), this difference was not significant, possibly due to the small sample size. These findings contrasted with those from self-report measures, which revealed significantly more cases of depression following mild TBI (64%) (mixed samples = 36%; severe TBI = 39%). There are a number of factors that may contribute to the latter finding. For example, severe TBIs are more frequently associated with memory problems and impaired selfawareness (Evans et al., 2005) , which may reduce the number of symptoms that are endorsed on questionnaires (Malec et al., 2007) . Alternatively, persons with mild TBI may be exaggerating their symptoms for financial gain (Kurtz et al., 2007) . However, it is also possible that people do not receive adequate psychoeducational support following a mild TBI, which may increase their distress or, in the absence of significant physical injuries, they may focus on other problems (Malec et al., 2007) . Therefore, even following mild TBI, individuals should be monitored to ensure that these symptoms do not interfere with their recovery or quality of life.
Relative to others, people are more likely to be diagnosed with MDD/dysthymia (OR = 1.66), or experience clinically significant levels of depression (OR = 3.41) following a TBI. Even when contributing factors, such as pain and hospital/medical procedures, are taken into account, a TBI provides an additional, unique source of psychological distress. Similarly, TBI groups were nearly eight times more likely to be diagnosed with MDD/dysthymia, and over five times more likely to be classified as having clinically significant levels of depression, than members of the general community. Lastly, the family/friends/caregivers of those who have sustained a TBI reported suffering from high levels of depression (23%), indicating that they are also at considerable risk of developing depression, and may require monitoring and treatment to optimise their outcomes (Ergh et al., 2002; Ponsford et al., 2010) .
Finally, when the full spectrum of self-reported depressive symptoms was examined -ranging from normal to severe depression -it was found that individuals experienced moderately higher levels of depression following a TBI than their peers. This finding was impacted by the source of the controls, with the largest difference associated with people residing in the community, followed by significant others and then medical controls. This highlights the importance of selecting the appropriate norms or controls, based on the clinical or research question, to enable depression to be examined independently of a range of confounding variables. Specifically, medical controls endeavour to control for pain, other injuries and hospital routines/procedures ; significant others control for the increased levels of stress and emotional distress related to a family member's TBI ; and community controls enable an assessment of depression relative to people who are residing in the general community (Wacholder et al., 1992) .
Limitations and recommendations for future research
There are a number of limitations that warrant consideration. First, although prior TBIs and psychiatric history may contribute to the development of depression (Anstey et al., 2004; Fann et al., 2002) , these data were often not reported, or provided in a form that could not be compared (e.g., no major psychiatric illness, no prior hospitalisation, not currently using medication); precluding an analysis of these variables. Second, data were often combined across different injury categories (mild, moderate, severe), which meant that it was only possible to undertake a coarse-grained examination of TBI severity. Third, it was not possible to examine the impact of medications on the prevalence of depression because very few studies reported these data. Anti-depressant medications are likely to reduce symptoms and result in lower prevalence estimates, making this an important variable to consider. Fourth, it is possible that gender may have impacted on the prevalence of depression following TBI because females have a higher risk of developing depression (Kessler et al., 1993) , although males are more likely to sustain a TBI (Anstey et al., 2004) . Of the studies that reported the prevalence of MDD/dysthymia, only six provided gender-based data. While there was a trend for females to have higher rates of MDD/dysthymia in these studies (47% vs 34%), the difference was not significant.
It is recommended that researchers report participants' history of TBIs/psychiatric diagnoses and, ideally, provide subgroup data (mild/moderate/severe TBI; medicated vs unmedicated; males vs females), so that these variables can be examined in greater detail. Multivariate analyses of the data were not possible due to the variability in the research designs that have been used to examine the prevalence of depression following TBI. A large-scale study that evaluates the impact of these variables is now needed.
Conclusions
There is now a substantial body of research that has examined the prevalence of depression following TBI, but the estimates from individual studies vary widely. The challenges involved in interpreting these disparate findings are well-known, with researchers repeatedly noting that numerous methodological differences have made it difficult to compare findings and draw definitive conclusions (Koponen et al., 2011; Tsaousides et al., 2013; Whelan-Goodinson et al., 2009a) .
Overall, the prevalence of formally diagnosed MDD and dysthymia was 27%, although this varied depending on whether ICD-10 (14%), DSM-IV (25%) or DSM-III (47%) diagnostic criteria were used. The different interview schedules also yielded variable prevalence rates, ranging from 16% to 54%. MDD/dysthymia was more prevalent between 2 and 5 years post-injury (43%), compared with the acute/post-acute period (<6 months; 21%), short-term (≥6 months to <2 years; 27%), and long-term (≥5 years; 22%). In addition, the prevalence of MDD/dysthymia was substantially higher following severe TBI (30%) than mild TBI (16%), although this difference was not significant. Moreover, MDD/dysthymia is more common following TBI than it is after other injuries (OR = 1.55) and in the general community (OR = 7.69).
The overall prevalence of clinically significant 'cases' of depression, assessed using questionnaires, was 38%; although this rate varied considerably depending on the measure that was used (2-48%) and the method of administration (phone: 26%; mail: 46%). Unlike MDD and dysthymia, self-reported depression continued to increase over time (from 33% to 42%) and injury severity had a paradoxical effect, with more cases of depression following mild TBI (64%, severe TBI = 39%). The odds of developing depression after a TBI are more than five, three and two times higher than those living in the general community, the family and friends of the person who sustained the TBI, and other medical patients, respectively.
